Can co-stimulated tumor immunity be therapeutically efficacious?

Immunol Rev. 1995 Jun:145:123-45. doi: 10.1111/j.1600-065x.1995.tb00079.x.

Authors

K E Hellström¹, I Hellström, L Chen

Affiliation

¹ Bristol-Myers Pharmaceutical Research Institute, Seattle, WA 98121, USA.

PMID: 7590823
DOI: 10.1111/j.1600-065x.1995.tb00079.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
B7-1 Antigen / pharmacology*
CD28 Antigens / pharmacology*
Drug Synergism
Immunotherapy, Active*
Mice
Neoplasms, Experimental / therapy*
T-Lymphocytes / immunology*

Substances

B7-1 Antigen
CD28 Antigens